Entropy Technologies LP reduced its stake in The Walt Disney Company (NYSE:DIS) by 45.3% in the fourth quarter, selling 35,516 shares and owning 42,951 shares valued at $4.887 million. Despite this, other institutional investors modified their holdings, with some increasing their stakes significantly. Analysts currently have an average "Moderate Buy" rating and a consensus price target of $133.71 for Walt Disney.

Arax Advisory Partners decreased its stake in The Walt Disney Company by 45.4% in the fourth quarter, selling 31,311 shares and retaining 37,654 shares valued at $4.28 million. Despite this reduction, institutional ownership of Disney remains robust at 65.71%, with several other hedge funds actively adjusting their positions—some significantly increasing their holdings. Analysts maintain a largely positive outlook, with a "Moderate Buy" consensus and an average target price of $133.71 for DIS.

Brown Advisory Inc. has decreased its stake in SLB Limited by 26% in the fourth quarter, selling 721,326 shares and now owning over 2 million shares valued at $78.99 million. Despite this, other institutional investors have increased their holdings in SLB, and analysts have issued various "buy" ratings and increased price targets for the stock. SLB Limited also announced a quarterly dividend of $0.295 per share.

Arax Advisory Partners reduced its stake in HCA Healthcare by 40.8% in the fourth quarter, selling 3,880 shares and leaving it with 5,638 shares valued at approximately $2.63 million. Despite several institutional investors adjusting their holdings, major firms like State Street, Capital World Investors, and Geode Capital remain significant shareholders, with institutional and hedge funds collectively owning 62.73% of HCA stock. HCA reported $7.15 EPS on $19.11 billion in revenue for the quarter, missing profit but exceeding revenue expectations, and analysts maintain a "Moderate Buy" rating with an average target price of $506.14.

Northern Trust has received a license from the Central Bank of Ireland to establish The Northern Trust Company, Ireland Branch, enhancing its services for EU-domiciled clients. This expansion aligns with new regulatory frameworks like CRD VI and CRR III and reinforces Northern Trust's 25-year commitment to Ireland as a strategic location. The new branch will offer custodial, banking, and capital markets services, complementing its existing continental European bank in Luxembourg.

Bio Usawa, a biotechnology company focused on expanding access to biologic medicines in Africa, has appointed Dr. Aida Habtezion to its Board of Directors. Dr. Habtezion, formerly Chief Medical Officer at Pfizer and a professor at Stanford, brings extensive experience in academic medicine, research, and global biopharmaceutical leadership. Her appointment is expected to significantly contribute to Bio Usawa's mission of building sustainable biotechnology manufacturing capacity and improving access to therapies across Africa.

Landscape Capital Management L.L.C. significantly increased its stake in Raymond James Financial (NYSE:RJF) during the fourth quarter, acquiring an additional 8,608 shares to bring its total holdings to 16,134 shares valued at $2.59 million. Raymond James Financial recently reported strong quarterly earnings of $2.83 per share, surpassing analyst expectations, despite revenue slightly missing estimates. The company also declared a quarterly dividend of $0.54 per share, representing an annualized yield of about 1.4%.

Kennedy Capital Management LLC reduced its position in Johnson & Johnson (JNJ) by 18.6% in the fourth quarter, selling 13,465 shares. Despite this, Johnson & Johnson displays operational strength, including a dividend increase, strong quarterly earnings, and a "Moderate Buy" analyst rating. However, insider selling and ongoing talc-related legal headlines present potential challenges.

Kennedy Capital Management LLC reduced its stake in Merck & Co., Inc. by 16.7% in the fourth quarter, selling 16,448 shares and holding 82,139 shares valued at $8.65 million. Despite this, Merck saw strong institutional investor interest, positive earnings, and a maintained "Moderate Buy" consensus rating from analysts. The company also announced a quarterly dividend of $0.85 per share, yielding 2.9%.

KCM Investment Advisors LLC slightly reduced its NVIDIA stake by 2.1% in Q4 but still holds 368,450 shares valued at $68.7 million, making NVDA its 8th largest position. NVIDIA exceeded earnings expectations with EPS of $1.87 on $81.62 billion revenue, an 85.2% increase year-over-year, and announced an increased dividend and an $80 billion share buyback program. Analysts maintain a "Buy" consensus rating for the company.